![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics of Firsocostat, an Acetyl-CoA Carboxylase
(ACC) Inhibitor, and Cilofexor, a Selective Nonsteroidal
Farnesoid X Receptor (FXR) Agonist, in Participants with Severe Renal Impairment
|
|
|
AASLD 2021 Nov 12-15
Elijah J. Weber, Islam Younis, Cara Nelson, Dora Ding, Ann R. Qin, Ryan S. Huss, Robert P. Myers and Ahmed A. Othman
Gilead Sciences, Inc., Foster City, CA, USA
![1130211](../images/113021/113021-15/1130211.gif)
![1130212](../images/113021/113021-15/1130212.gif)
![1130213](../images/113021/113021-15/1130213.gif)
![1130214](../images/113021/113021-15/1130214.gif)
![1130215](../images/113021/113021-15/1130215.gif)
![1130216](../images/113021/113021-15/1130216.gif)
![1130217](../images/113021/113021-15/1130217.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|